Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

As we transition lead commercial activities to Sanofi, this will enable the reduction of commercial and supply chain costs.

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...

Q3 2024 Earnings Call Transcript October 25, 2024 Sanofi beats earnings expectations. Reported EPS is $1.57, expectations ...

The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in children as young as one year of age. Specifically, the approval covers children aged one to ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

Sanofi announced last Friday that it was negotiating ... the Commission has stressed the importance of reinforcing global supply chains of medicines based on diversification and the need for ...

Sanofi and Sudair Pharma Company (SPC ... NUPCO works to manage the entire medical supply chains for government health entities and manages procurement operations and competitions, which aim to ...

chain structures, segmentation and sub-segments so on. It highlights various modifications held in the market to improve the market growth. The market report reviews the effect of demand, supply, ...

Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...